Fortress Biotech (FBIOP) Stock Price, Quote, News & History

Fortress Biotech Inc (FBIOP) Stock Price, Quote, News & History

FBIOPNASDAQ

Trade with Public

$13.55

-0.085-0.62%

At close: Mar 10, 5:00 PM EST

$13.65

0.0150.11%

Pre-Market: 4:09 AM EST

Key Statistics

Open

$13.55

Volume / Avg.

0 / 28.39K

Day Range

- - -

52 Wk Range

4.72 - 14.64

Market Cap

$46.78M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Fortress Biotech Inc News

13 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Benzinga Newsdesk

12 Biotechnology Stocks Moving In Wednesday's Pre-Market Session

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-66.14M

Investing Cash Flow (TTM)

-4.88M

Financing Cash Flow (TTM)

97.54M

Free Cash Flow (TTM)

-81.14M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

26.52M

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$53.40M

LT Debt

$47.77M

LT Debt Issuance (TTM)

$5.00M

LT Debt Repayment (TTM)

-$5.64M

Total Cash

$86.22M

Debt to Equity

1.22

Issuance of Debt (TTM)

-$634.00K

Repayment of Debt (TTM)

-$5.64M

Key Statistics

Open

$13.55

Volume / Avg.

0 / 28.39K

Day Range

- - -

52 Wk Range

4.72 - 14.64

Market Cap

$46.78M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Tar...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Fortress Biotech (FBIOP) stock?

You can purchase shares of Fortress Biotech (NASDAQ:FBIOP) through any online brokerage.

View our list of the best stock brokerages

Who are Fortress Biotech (FBIOP) competitors?

Other companies in Fortress Biotech’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Estrella Immunopharma Inc (NASDAQ:ESLA), Aligos Therapeutics Inc (NASDAQ:ALGS), Atossa Therapeutics Inc (NASDAQ:ATOS) and Forum Markets Inc (NASDAQ:FRMM).

What is the forecast, or price target, for Fortress Biotech (FBIOP) stock?

There is no analysis for Fortress Biotech to provide a consensus price target.

What is the current price for Fortress Biotech (FBIOP)?

The stock price for Fortress Biotech (NASDAQ: FBIOP) is $13.65 last updated March 10, 2026 at 4:44 PM EDT.

Does Fortress Biotech (FBIOP) pay a dividend?

There are no upcoming dividends for Fortress Biotech.

When is Fortress Biotech (NASDAQ:FBIOP) reporting earnings?

Fortress Biotech does not have any upcoming earnings scheduled.

Is Fortress Biotech (FBIOP) going to split?

There is no upcoming split for Fortress Biotech.

What sector and industry does Fortress Biotech (FBIOP) operate in?

Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Kezar Life Sciences Inc

NASDAQ:KZR

$6.88

-2.03%

Estrella Immunopharma Inc

NASDAQ:ESLA

$1.24

1.61%

Aligos Therapeutics Inc

NASDAQ:ALGS

$7.97

5.02%

Atossa Therapeutics Inc

Lisata Therapeutics Inc

NASDAQ:LSTA

$5.05

0.40%

Key Statistics

Open

$13.55

Volume / Avg.

0 / 28.39K

Day Range

- - -

52 Wk Range

4.72 - 14.64

Market Cap

$46.78M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Fortress Biotech Inc News

13 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Benzinga Newsdesk

12 Biotechnology Stocks Moving In Wednesday's Pre-Market Session

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-66.14M

Investing Cash Flow (TTM)

-4.88M

Financing Cash Flow (TTM)

97.54M

Free Cash Flow (TTM)

-81.14M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

26.52M

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$53.40M

LT Debt

$47.77M

LT Debt Issuance (TTM)

$5.00M

LT Debt Repayment (TTM)

-$5.64M

Total Cash

$86.22M

Debt to Equity

1.22

Issuance of Debt (TTM)

-$634.00K

Repayment of Debt (TTM)

-$5.64M

Key Statistics

Open

$13.55

Volume / Avg.

0 / 28.39K

Day Range

- - -

52 Wk Range

4.72 - 14.64

Market Cap

$46.78M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry